ArticleTherapeutic advances in neurological disorders2020

Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study.

Saiju Jacob et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.